Sanofi, the pharmaceutical major, has entered into a partnership with Google to establish a new virtual Innovation Lab.
The partnership venture aims to radically transform how future medicines and health services are delivered, by tapping into the power of emerging data technologies.
“We stand on the forefront of a new age for biology and human health, with the opportunity to transform healthcare through partnerships with pioneering technology and analytics companies,” said Ameet Nathwani, MD, Chief Digital Officer, Chief Medical Officer & Executive Vice President, Medical, at Sanofi.
Combining Sanofi’s biologic innovations and scientific data with Google’s industry-leading capabilities, from cloud computing to state-of-the-art artificial intelligence, the company looks to give people more control over their health and accelerate the discovery of new therapies, Sanofi said in a statement.
The collaboration aims to change how Sanofi develops new treatments and will focus on three key objectives: to better understand patients and diseases, to increase Sanofi’s operational efficiency, and to improve the experience of Sanofi’s patients and customers.
“Life sciences companies are looking to data-driven, digital innovation to help fuel the creation of accessible healthcare solutions,” said Thomas Kurian, CEO, Google Cloud.
The Innovation Lab will develop both scientific and commercial solutions.
Sanofi and Google will leverage deep analytics across data sets to better understand key diseases and extract related patient insights. This will enable Sanofi to research and develop more personalised approaches to treatment and identify accompanying technologies to improve health outcomes.
The companies will apply technology and analytics on Sanofi’s large, real-world database to better understand what treatments work for patients. This aims to result in an improved ability to offer personalised treatment advice, thus optimising patient care and reducing healthcare costs.
Sanofi and Google also plan to apply artificial intelligence (AI) across diverse datasets to better forecast sales and inform marketing and supply chain efforts. Using AI will take into account real-time information as well as geographic, logistic and manufacturing constraints to help the accuracy of these complex activities, according to the statement.